AKT1 and prostate adenocarcinoma: Genistein inhibits growth and enhances apoptosis of LNCaP (human prostate adenocarcinoma) cells, partially due to down-regulation of the expression of EGF and HER2/Neu receptors, inhibition of Akt activity and due to Akt-mediated NF-κB activation [1,70].